Related references
Note: Only part of the references are listed.Oral antithrombotic therapy for the prevention of recurrent cerebrovascular events
Davide Capodanno et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)
Mechanical thrombectomy with retrievable stents and aspiration catheters for acute ischaemic stroke: a meta-analysis of randomised controlled trials
Christopher A. Rajkumar et al.
EUROINTERVENTION (2022)
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Genotype-Guided Antiplatelet Therapy in Patients With Coronary Artery Disease
Francesco Franchi et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2021)
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Mattia Galli et al.
LANCET (2021)
Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events
Dario Calderone et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
Dawn O. Kleindorfer et al.
STROKE (2021)
European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA
Jesse Dawson et al.
EUROPEAN STROKE JOURNAL (2021)
Comparison of prasugrel and clopidogrel in patients with non-cardioernbolic ischaernic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I) (vol 18, pg 238, 2019)
A. Ogawa et al.
LANCET NEUROLOGY (2020)
Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel The ABCD-GENE Score
Dominick J. Angiolillo et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease
Davide Capodanno et al.
NATURE REVIEWS CARDIOLOGY (2020)
Use of Dual Antiplatelet Therapy Following Ischemic Stroke
Junling Dong et al.
STROKE (2020)
Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke
Ken S. Butcher et al.
STROKE (2020)
New Horizons in Pharmacologic Therapy for Secondary Stroke Prevention
Aristeidis H. Katsanos et al.
JAMA NEUROLOGY (2020)
Insights from Experiences on Antiplatelet Drugs in Stroke Prevention: A Review
Salvatore Santo Signorelli et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
Pierre Amarenco et al.
STROKE (2020)
An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitus
Dario Calderone et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2020)
Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II
Kazuo Kitagawa et al.
CEREBROVASCULAR DISEASES (2020)
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
Kazunori Toyoda et al.
LANCET NEUROLOGY (2019)
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials
Yuesong Pan et al.
JAMA NEUROLOGY (2019)
Stroke Outcomes in the COMPASS Trial
Mukul Sharma et al.
CIRCULATION (2019)
Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack An Overview of Major Trials and Meta-Analyses
Daniel G. Hackam et al.
STROKE (2019)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I)
Akira Ogawa et al.
LANCET NEUROLOGY (2019)
Aspirin for the primary prevention of cardiovascular disease: latest evidence
Davide Capodanno et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2019)
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Victor Aboyans et al.
EUROPEAN HEART JOURNAL (2018)
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
Philip M. Bath et al.
LANCET (2018)
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Updates on Prevention of Cardioembolic Strokes
Mehmet Akif Topcuoglu et al.
JOURNAL OF STROKE (2018)
Recanalization Rate per Retrieval Attempt in Mechanical Thrombectomy for Acute Ischemic Stroke
Fabian Flottmann et al.
STROKE (2018)
Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study
Xiaowen Hou et al.
STROKE AND VASCULAR NEUROLOGY (2018)
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
Marie D. Gerhard-Herman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial
Pierre Amarenco et al.
LANCET NEUROLOGY (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
Mayank Goyal et al.
LANCET (2016)
Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
Peter M. Rothwell et al.
LANCET (2016)
Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease
Davide Capodanno et al.
NATURE REVIEWS CARDIOLOGY (2016)
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease
Simon Barquera et al.
ARCHIVES OF MEDICAL RESEARCH (2015)
Factor XI and contact activation as targets for antithrombotic therapy
D. Gailani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Initial 3-Weeks' Apixaban Versus Dual-Antiplatelet Therapy (Clopidogrel and Aspirin) Followed by Clopidogrel Alone in High-Risk Patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): Study Protocol for a Randomized Controlled Trial
Fang Yang et al.
CLINICAL DRUG INVESTIGATION (2014)
Association between Ischemic Stroke and Vascular Shear Stress in the Carotid Artery
Seul-Ki Jeong et al.
JOURNAL OF CLINICAL NEUROLOGY (2014)
The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials
Xia Li et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Edward C. Jauch et al.
STROKE (2013)
Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial
Graeme J. Hankey et al.
INTERNATIONAL JOURNAL OF STROKE (2011)
Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events
Anetta Undas et al.
THROMBOSIS RESEARCH (2011)
Primary and Secondary Prevention of Ischemic Stroke
Maurizio Paciaroni et al.
EUROPEAN NEUROLOGY (2010)
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
Yukito Shinohara et al.
LANCET NEUROLOGY (2010)
Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke Real-World Experience and a Call for Action
Rohit Bhatia et al.
STROKE (2010)
Effect of Clopidogrel on the Rate and Functional Severity of Stroke Among High Vascular Risk Patients A Prespecified Substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Trial
Graeme J. Hankey et al.
STROKE (2010)
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
Ophira Salomon et al.
BLOOD (2008)
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development
Dominick J. Angiolillo et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk
P. H. A. Halkes et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Ralph L. Sacco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cilostazol: Potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding
Shinya Goto
ATHEROSCLEROSIS SUPPLEMENTS (2005)
Drug therapy -: Low-dose aspirin for the prevention of atherothrombosis
C Patrono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Dipyridamole for preventing recurrent ischemic stroke and other vascular events - A meta-analysis of individual patient data from randomized controlled trials
J Leonardi-Bee et al.
STROKE (2005)
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events
PA Ringleb et al.
STROKE (2004)
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
HC Diener et al.
LANCET (2004)
Indications for early aspirin use in acute ischemic stroke - A combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial
ZM Chen et al.
STROKE (2000)
Share Paper
